Spots Global Cancer Trial Database for The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC）
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC）
Official Title: The Prospective,Multicenter,Randomized Controlled Clinical Study of the Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC）
Study ID: NCT02076477
Study Description
Brief Summary: This study evaluates the optimal intervention time of radiotherapy for oligometastatic stage iv lung cancer.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Sichuan Cancer Hospital & Institute, Chengdu, Sichuan, China
Contact Details
Name: JIAHUA LV, MD
Affiliation: Sichuan Cancer Hospital & Institute
Role: PRINCIPAL_INVESTIGATOR
Name: XIAOHU WANG, MD, PhD
Affiliation: Gansu Cancer Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: XIAOBO DU, MD, PhD
Affiliation: Mianyang Central Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: BING LU, MD.PhD
Affiliation: Cancer Hospital of Guizhou Province
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
